Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report
Half-year ReportInterim Results for the period ended 30 June 2026 LONDON, UK / ACCESS Newswire / September 28, 2026 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the"Company") (LSE:HEMO), the biopharmaceutical group developing …
Weiterlesen »